Hypochondroplasia

• CLINICAL_TRIALS research · 2026-03-31
  Clinical Trial Update: A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 Months [Phase 2]

  A Phase 2 study evaluating Vosoritide versus placebo in children with hypochondroplasia aged 0 to < 36 months is currently recruiting.

• CLINICAL_TRIALS research · 2026-02-20
  Clinical Trial Update: Prospective Longitudinal Monocentric Study to Measure Limb Movement in Patients With FGFR3-related Skeletal Dysplasia

  Prospective, monocentric study sponsored by SYSNAV to measure limb movement in patients with FGFR3-related skeletal dysplasia. Recruitment i…

• CLINICAL_TRIALS research · 2026-01-20
  Clinical Trial Update: Interventional Study of Vosoritide for the Treatment of Children With Hypochondroplasia [Phase 3]

  A Phase 3 interventional trial evaluating Vosoritide for hypochondroplasia in children is active but not recruiting. This document updates t…

• CLINICAL_TRIALS research · 2025-12-15
  Clinical Trial Update: An Interventional Study of Infigratinib in Children With Hypochondroplasia [Phase 2, Phase 3]

  Interventional Phase 2/3 study of Infigratinib in children with hypochondroplasia is currently enrolling by invitation.

• CLINICAL_TRIALS research · 2025-10-10
  Clinical Trial Update: Prospective Clinical Assessment Study in Children With Hypochondroplasia

  Clinical trial update for a prospective study in children with hypochondroplasia; recruitment is ongoing.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2025-04-03
  Clinical Trial Update: A Multicenter Multinational Observational Study of Children With Hypochondroplasia

  Multicenter multinational observational study in children with hypochondroplasia sponsored by BioMarin Pharmaceutical; currently recruiting.